NCT03735316 - Vitamin B12a Vasoplegic Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 25, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions

Vasoplegic Syndrome

Interventions

DRUG

Hydroxocobalamin

5g, IV, Infused once over 15 minutes. The drug comes in a 250ml glass vial with 5g of lyophilized hydroxocobalamin to be reconstituted in 200ml of Normal Saline, Dextrose or Lactated Ringers.

PROCEDURE

Cardiopulmonary Bypass

Technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the patient's body.

DRUG

Placebos

Placebo is a Normal Saline, 5g, IV, Infused once over 15 minutes. The placebo comes in a 250ml glass vial.

Trial Locations (1)

55902

Mayo Clinic Saint Mary's Hospital, Rochester